Target Residence Time-Guided Optimization on TTK Kinase Results in Inhibitors with Potent Anti-Proliferative Activity

激酶 变构调节 癌症研究 化学 药理学 生物化学 酶 医学
作者
Joost C.M. Uitdehaag,Jos de Man,Nicole Willemsen‐Seegers,Martine B.W. Prinsen,Marion A.A. Libouban,Jan Gerard Sterrenburg,Joeri J.P. de Wit,Judith R.F. de Vetter,Jeroen A.D.M. de Roos,Rogier C. Buijsman,Guido J.R. Zaman
出处
期刊:Journal of Molecular Biology [Elsevier BV]
卷期号:429 (14): 2211-2230 被引量:67
标识
DOI:10.1016/j.jmb.2017.05.014
摘要

The protein kinase threonine tyrosine kinase (TTK; also known as Mps1) is a critical component of the spindle assembly checkpoint and a promising drug target for the treatment of aggressive cancers, such as triple negative breast cancer. While the first TTK inhibitors have entered clinical trials, little is known about how the inhibition of TTK with small-molecule compounds affects cellular activity. We studied the selective TTK inhibitor NTRC 0066-0, which was developed in our own laboratory, together with 11 TTK inhibitors developed by other companies, including Mps-BAY2b, BAY 1161909, BAY 1217389 (Bayer), TC-Mps1-12 (Shionogi), and MPI-0479605 (Myrexis). Parallel testing shows that the cellular activity of these TTK inhibitors correlates with their binding affinity to TTK and, more strongly, with target residence time. TTK inhibitors are therefore an example where target residence time determines activity in in vitro cellular assays. X-ray structures and thermal stability experiments reveal that the most potent compounds induce a shift of the glycine-rich loop as a result of binding to the catalytic lysine at position 553. This "lysine trap" disrupts the catalytic machinery. Based on these insights, we developed TTK inhibitors, based on a (5,6-dihydro)pyrimido[4,5-e]indolizine scaffold, with longer target residence times, which further exploit an allosteric pocket surrounding Lys553. Their binding mode is new for kinase inhibitors and can be classified as hybrid Type I/Type III. These inhibitors have very potent anti-proliferative activity that rivals classic cytotoxic therapy. Our findings will open up new avenues for more applications for TTK inhibitors in cancer treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
2秒前
2秒前
xzy666的应助被zhiwei采纳,获得10
3秒前
lizi完成签到,获得积分10
4秒前
4秒前
5秒前
6秒前
FashionBoy的应助被苗条书桃采纳,获得30
7秒前
牛牛发布了新的文献求助10
7秒前
周芷卉发布了新的文献求助10
8秒前
tlc_191026发布了新的文献求助10
9秒前
10秒前
daomaihu发布了新的文献求助100
10秒前
10秒前
无花果的应助被激动的绿竹采纳,获得10
10秒前
Stella发布了新的文献求助10
11秒前
11秒前
爆米花的应助被六六大顺采纳,获得10
11秒前
复古红完成签到,获得积分10
11秒前
哇晒完成签到 ,获得积分10
11秒前
nhzz2023发布了新的文献求助10
11秒前
11秒前
Lucas的应助被ZZ采纳,获得10
11秒前
11秒前
香蕉觅云的应助被applecat147采纳,获得10
12秒前
13秒前
13秒前
13秒前
歪歪歪完成签到 ,获得积分10
14秒前
15秒前
脑洞疼的应助被陈哈哈采纳,获得10
15秒前
科研通AI6.3的应助被牧百川采纳,获得10
15秒前
vancomycin完成签到,获得积分10
15秒前
文艺山灵完成签到 ,获得积分10
15秒前
16秒前
16秒前
16秒前
INFINITY发布了新的文献求助10
16秒前
INFINITY发布了新的文献求助10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183449
求助须知:如何正确求助?哪些是违规求助? 9572834
关于积分的说明 21827509
捐赠科研通 7780646
什么是DOI,文献DOI怎么找? 3434016
关于科研通互助平台的介绍 2558189
邀请新用户注册赠送积分活动 2480371